Patient Compliance

1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Pfizer
PfizerNEW YORK, NY
1 program
1
Ibuprofen 400 mg capletPhase 31 trial
Active Trials
NCT02294019Completed738Est. May 2015
R
ResMedCA - San Diego
1 program
Automatic Positive Airway PressureN/A1 trial
Active Trials
NCT02339597Unknown224Est. Nov 2015

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
PfizerIbuprofen 400 mg caplet
ResMedAutomatic Positive Airway Pressure

Clinical Trials (2)

Total enrollment: 962 patients across 2 trials

NCT02294019PfizerIbuprofen 400 mg caplet

Actual Use Trial of Ibuprofen 400 mg

Start: Nov 2014Est. completion: May 2015738 patients
Phase 3Completed
NCT02339597ResMedAutomatic Positive Airway Pressure

Therapy Adherence of APAP Therapy Initiation in Sleep-lab Versus at Home

Start: Jan 2014Est. completion: Nov 2015224 patients
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
2 companies competing in this space